MediWound Q2 revenue up 43%, beats estimates
Overview
MediWound Q2 2025 revenue rises 43% sequentially, beating analysts' expectations
Net loss widens to $13.3 mln, driven by non-cash financial expenses
Co establishes strategic research collaborations with Essity and Convatec for EscharEx trials
Outlook
Company expects full operational capacity for NexoBrid by year-end 2025
Company received $3.6 mln from U.S. DoD for NexoBrid development
MediWound continues EscharEx Phase III trial enrollment with new partnerships
Result Drivers
NEXOBRID ADOPTION - U.S. adoption of NexoBrid continues to grow, with Vericel reporting 52% year-over-year revenue growth
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Beat | $5.70 mln | $5.68 mln (6 Analysts) |
Q2 EPS |
| -$1.23 |
|
Q2 Net Income |
| -$13.30 mln |
|
Q2 Adjusted EBITDA | Miss | -$4.50 mln | -$4.25 mln (2 Analysts) |
Q2 Gross Profit |
| $1.30 mln |
|
Q2 Operating Income |
| -$5.70 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the pharmaceuticals peer group is "buy"
Wall Street's median 12-month price target for Mediwound Ltd is $30.50, about 38.5% above its August 13 closing price of $18.75
Press Release: ID:nGNXb8gMFJ
Related Articles
NVIDIA Q2 FY2026: Surfing the AI Surge with Blackwell, Steering Through China’s Export Challenges
TradingKey - NVIDIA Corporation (NASDAQ: NVDA) reported strong Q2 FY2026 results on August 27, 2025, after market close, driven by robust AI-powered demand and adoption of its next-generation Blackwell GPU platform. The company delivered significant revenue and profit beats overall, with...
U.S. Dollar Index: Assessing Its Future Trend Through Macro Analysis of the U.S., Eurozone, Japan, and U.K.
TradingKey - Looking ahead, in the U.S., slowing economic growth combined with ongoing interest rate cuts will exert downward pressure on the dollar. In the Eurozone, weak economic performance and continued ECB rate cuts will likely depreciate the euro, indirectly supporting the U.S. Dollar Index...
Eurozone Q2 GDP Commentary: Will the Euro's Upward Momentum Persist?
TradingKey - On 14 August 2025, Eurostat published Q2 GDP figures, revealing a drop in the Eurozone's quarter-on-quarter growth from 0.6% in the first quarter to 0.1%. Consequently, annual growth eased from 1.5% to 1.4%. The slowdown primarily stems from the diminishing boost from European...
Bitcoin Price Forecast: Trends and Investment Outlook from 2025 to 2030
From $0.01 in 2009 to $120,000+ in 2025, Bitcoin has evolved from obscurity to a globally recognized financial asset. While institutions and governments increasingly embrace it, investors must remain vigilant against volatility, security risks, and scams.
What’s Driving the Japanese Bond Sell-Off? The Root — Life Insurers’ Negative Duration Gap
TradingKey - As the Bank of Japan (BoJ) enters a tightening cycle, Japanese government bond (JGB) yields have been rising steadily. However, the recent sharp selloff in Japan bonds appears unusually severe.
